Simcere Pharmaceutical Group Limited (HKG:2096)
13.62
+0.10 (0.74%)
Apr 2, 2026, 4:08 PM HKT
HKG:2096 Revenue
In the year 2025, Simcere Pharmaceutical Group had annual revenue of 7.73B CNY with 16.52% growth. Simcere Pharmaceutical Group had revenue of 4.15B in the half year ending December 31, 2025, with 28.53% growth.
Revenue
7.73B CNY
Revenue Growth
+16.52%
P/S Ratio
4.09
Revenue / Employee
1.13M CNY
Employees
6,815
Market Cap
35.18B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 7.73B | 1.10B | 16.52% |
| Dec 31, 2024 | 6.64B | 27.41M | 0.41% |
| Dec 31, 2023 | 6.61B | 283.72M | 4.49% |
| Dec 31, 2022 | 6.32B | 1.32B | 26.49% |
| Dec 31, 2021 | 5.00B | 491.00M | 10.89% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2012 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| China Resources Pharmaceutical Group | 299.99B |
| The United Laboratories International Holdings | 14.70B |
| Grand Pharmaceutical Group | 12.28B |
| China Medical System Holdings | 9.14B |
| Luye Pharma Group | 7.02B |
| Sunshine Lake Pharma | 3.96B |
| Consun Pharmaceutical Group | 3.80B |
| Sihuan Pharmaceutical Holdings Group | 2.91B |